The Oligonucleotide Therapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Oligonucleotide Therapy Market?
The market size of the oligonucleotide therapy saw a swift growth in the recent past. The market was valued at $5.55 billion in 2024 and is projected to reach $6.18 billion by 2025, growing at a compound annual growth rate (CAGR) of 11.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Oligonucleotide Therapy Industry?
The Oligonucleotide Therapy Global Market is projected to reach $9.82 billion in 2029, with a compound annual growth rate (CAGR) of 12.3%.
Download Your Free Sample of the 2025 Oligonucleotide Therapy Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Oligonucleotide Therapy Market?
The key drivers in the oligonucleotide therapy market are:
• Increased investment in research and development
• Enhanced global market penetration
• Expansion in the therapeutic area
• Adoption of disease modification strategies
• Regulatory adaptations in the field.
Global Market Segmentation: Identifying Major Oligonucleotide Therapy Industry Segments
The oligonucleotide therapy market covered in this report is segmented –
1) By Type: Antisense Oligonucleotide, Aptamer, Other Types
2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User
3) By End User: Hospitals, Research Institutes
Pre-order the 2025 Oligonucleotide Therapy Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Oligonucleotide Therapy Market?
The key trends in the oligonucleotide therapy market are:
• Customized therapies are becoming a significant trend in the oligonucleotide therapy market.
• There are upcoming advancements in delivery systems in the field.
• RNA interference (RNAI) advancements are increasingly influencing the market.
• Integration of gene editing techniques is emerging as a trend.
Who Are the Top Competitors & Leading Players in the Oligonucleotide Therapy Market?
Major companies in the oligonucleotide therapy market are:
• Pfizer Inc.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• BioNTech SE
• Moderna Inc.
• Biogen Inc.
• Jazz Pharmaceuticals plc
• QIAGEN Company
• Alnylam Pharmaceuticals Inc.
• Sarepta Therapeutics Inc.
• Ionis Pharmaceuticals Inc.
• Akcea Therapeutics Inc.
• Arrowhead Pharmaceuticals Inc.
• Dicerna Pharmaceuticals Inc.
• SomaGenics Inc.
• Wave Life Sciences Ltd.
• Exicure Inc.
• Avidity Biosciences Inc.
• Miragen Therapeutics Inc.
• ProQR Therapeutics NV
• Regulus Therapeutics Inc.
• Kastle Therapeutics LLC
• Santaris Pharma A/S
• InteRNA Technologies B.V.
• Dynacure S.A.
• Arcturus Therapeutics Holdings Inc.
• Intellia Therapeutics Inc.
• Regeneron Pharmaceuticals Inc.
• Editas Medicine Inc.
• Evox Therapeutics Ltd.
• PepGen Ltd.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the oligonucleotide therapy market in 2024
